Improvement in patient-reported outcomes for patients with ankylosing spondylitis treated with etanercept 50 mg once-weekly and 25 mg twice-weekly

J Braun, Neil J McHugh, A Singh, J S Wajdula, R Sato

Research output: Contribution to journalArticlepeer-review

74 Citations (Scopus)

Abstract

The more convenient etanercept 50 mg QW dose regimen significantly improves function and QOL in patients with AS, similarly to the standard dosing of 25 mg BIW, supporting its use for AS therapy.
Original languageEnglish
Pages (from-to)999-1004
Number of pages6
JournalRheumatology
Volume46
Issue number6
DOIs
Publication statusPublished - 2007

Fingerprint Dive into the research topics of 'Improvement in patient-reported outcomes for patients with ankylosing spondylitis treated with etanercept 50 mg once-weekly and 25 mg twice-weekly'. Together they form a unique fingerprint.

Cite this